Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2007

View Archived Issues

Emisphere reports data on oral delivery of GLP-1 and PYY

Alpharma licenses novel technology from Tris Pharma

Enzon studies HIF-1 alpha antagonist in phase I trial

Safety and pharmacokinetics established for XTL-6865 in HCV

MedImmune licenses reverse genetics intellectual property to sanofi pasteur

VioQuest adds two new products to pipeline

Athersys achieves commercial collaboration milestones

Pivotal study of romidepsin in CTCL cleared to continue

Takeda acquires rights to R-851 from 3M

Galapagos achieves milestones in GSK osteoarthritis collaboration

Development of Pevion's malaria vaccine supported by E.U. grant

Phase II study of LE-SN38 misses primary tumor response endpoint

Topical interferon alpha-2b shows clinically efficacious response in LSIL

Berlex reports on novel CCR5 antagonists

Recent patents impart new therapeutic agents for cancer

IND clearance sought for phase II ophthalmic study of Tbeta4 eye drops

Parkinson's disease drug pergolide withdrawn

EMEA recommends restrictions on use of Ketek

Lutetium-177-labeled monoclonal antibody cG250 appears safe in renal cell carcinoma

V-HeFT I and II formulations of isosorbide dinitrate/hydralazine not bioequivalent

Nicotine patch appears safe for use in coronary artery disease patients

Novel KCNQ2 channel opener shows antiepileptic activity in mice

Novel treatment options for inflammatory disorders claimed in recent GSK and Palau patents

Novel therapeutic agents for immunological disorders disclosed in recent patents

Cardiome Pharma updates status of key programs

Lucentis launched in the U.K.

Transition receives fast track designation for Alzheimer's disease drug candidate

Santen seeks European approval of tafluprost

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...